416 reports of this reaction
1.4% of all MAGNESIUM SULFATE IN WATER FOR reports
#20 most reported adverse reaction
PREMATURE DELIVERY is the #20 most commonly reported adverse reaction for MAGNESIUM SULFATE IN WATER FOR, manufactured by AVADIM HOLDINGS, INC.. There are 416 FDA adverse event reports linking MAGNESIUM SULFATE IN WATER FOR to PREMATURE DELIVERY. This represents approximately 1.4% of all 29,923 adverse event reports for this drug.
Patients taking MAGNESIUM SULFATE IN WATER FOR who experience premature delivery should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PREMATURE DELIVERY is a less commonly reported adverse event for MAGNESIUM SULFATE IN WATER FOR, but still significant enough to appear in the safety profile.
In addition to premature delivery, the following adverse reactions have been reported for MAGNESIUM SULFATE IN WATER FOR:
The following drugs have also been linked to premature delivery in FDA adverse event reports:
PREMATURE DELIVERY has been reported as an adverse event in 416 FDA reports for MAGNESIUM SULFATE IN WATER FOR. This does not prove causation, but indicates an association observed in post-market surveillance data.
PREMATURE DELIVERY accounts for approximately 1.4% of all adverse event reports for MAGNESIUM SULFATE IN WATER FOR, making it a notable side effect.
If you experience premature delivery while taking MAGNESIUM SULFATE IN WATER FOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.